Titan Historical Cash Flow
| TTNP Stock | USD 3.98 0.06 1.53% |
Analysis of Titan Pharmaceuticals cash flow over time is an excellent tool to project Titan Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 1.7 K or Total Cash From Financing Activities of 9.6 M as it is a great indicator of Titan Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Titan Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Titan Pharmaceuticals is a good buy for the upcoming year.
Titan |
About Titan Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Titan balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Titan's non-liquid assets can be easily converted into cash.
Titan Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Titan Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Titan Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.At this time, Titan Pharmaceuticals' Cash And Cash Equivalents Changes is relatively stable compared to the past year. As of 03/01/2025, Investments is likely to grow to about 275.3 K, while Begin Period Cash Flow is likely to drop slightly above 2.7 M.
Titan Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Titan Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Titan Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 190K | 919K | (3.2M) | 3.6M | 3.3M | 3.4M | |
| Free Cash Flow | (17.7M) | (7.9M) | (8.2M) | (7.1M) | (8.2M) | (8.6M) | |
| Change In Working Capital | 1.0M | (219K) | 378K | (916K) | (824.4K) | (783.2K) | |
| Begin Period Cash Flow | 5.2M | 5.4M | 6.3M | 3.1M | 2.8M | 2.7M | |
| Other Cashflows From Financing Activities | 7.2M | (23K) | 4K | 9.5M | 10.9M | 11.5M | |
| Depreciation | 292K | 221K | 196K | 112K | 100.8K | 95.8K | |
| Other Non Cash Items | 482K | (5K) | 452K | (1.7M) | (1.6M) | (1.5M) | |
| Capital Expenditures | 256K | 540K | 23K | 2K | 1.8K | 1.7K | |
| Total Cash From Operating Activities | (17.2M) | (7.9M) | (8.2M) | (7.1M) | (8.2M) | (8.6M) | |
| Net Income | (18.2M) | (8.8M) | (10.2M) | (5.6M) | (6.4M) | (6.7M) | |
| Total Cash From Financing Activities | 17.9M | 8.8M | 5.0M | 10M | 9M | 9.6M | |
| End Period Cash Flow | 5.4M | 6.3M | 3.1M | 6.8M | 6.1M | 8.8M | |
| Stock Based Compensation | 7K | 1.5M | 997K | 1.0M | 1.2M | 1.1M | |
| Total Cashflows From Investing Activities | (416K) | (256K) | (540K) | (23K) | (20.7K) | (19.7K) | |
| Change To Account Receivables | 186K | 642K | 76K | (10K) | (11.5K) | (12.1K) | |
| Change To Inventory | 287K | 35K | 187K | 354K | 407.1K | 427.5K | |
| Change To Netincome | 620K | (192K) | (271K) | 875K | 787.5K | 557.4K | |
| Change To Liabilities | 985K | (95K) | 1.1M | (896K) | (1.0M) | (1.1M) | |
| Change To Operating Activities | 258K | 292K | (556K) | (130K) | (117K) | (111.2K) | |
| Investments | (540K) | (23K) | (5K) | 228K | 262.2K | 275.3K | |
| Issuance Of Capital Stock | 11.6M | 8.8M | 5.0M | 9.1M | 8.2M | 7.2M |
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.